Chelsea Kaplan1, Alexa Minc2, Neil Basu3, Andrew Schrepf4. 1. Chronic Pain and Fatigue Research Center, Department of Anesthesiology, University of Michigan Health System, Domino's Farms, Lobby M, 24 Frank Lloyd Wright Dr., PO Box 385, Ann Arbor, MI, 48106, USA. 2. Michigan Medicine, Ann Arbor, MI, USA. 3. Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK. 4. Chronic Pain and Fatigue Research Center, Department of Anesthesiology, University of Michigan Health System, Domino's Farms, Lobby M, 24 Frank Lloyd Wright Dr., PO Box 385, Ann Arbor, MI, 48106, USA. aschrepf@med.umich.edu.
Abstract
PURPOSE OF REVIEW: To review how peripheral inflammation in rheumatic disease influences the central nervous system. We consider recent studies of rheumatic disease that employ functional and structural neuroimaging in the context of inflammation, as well as recent studies considering how immunosuppressive therapy is associated with changes in brain function and structure. RECENT FINDINGS: The most compelling evidence thus far comes from studies of rheumatoid arthritis and indicates that higher levels of inflammation are associated with changes in cognitive, affective, and pain-processing brain regions, some of which may be rectified by anti-inflammatory treatment. Comorbid symptoms such as widespread pain and fatigue may also be associated with these changes. Inflammation may be associated with compensatory activation of brain regions to offset structural changes. This emerging line of evidence suggests that communication between the brain and immune system are an important and underappreciated aspect of inflammatory rheumatic disease.
PURPOSE OF REVIEW: To review how peripheral inflammation in rheumatic disease influences the central nervous system. We consider recent studies of rheumatic disease that employ functional and structural neuroimaging in the context of inflammation, as well as recent studies considering how immunosuppressive therapy is associated with changes in brain function and structure. RECENT FINDINGS: The most compelling evidence thus far comes from studies of rheumatoid arthritis and indicates that higher levels of inflammation are associated with changes in cognitive, affective, and pain-processing brain regions, some of which may be rectified by anti-inflammatory treatment. Comorbid symptoms such as widespread pain and fatigue may also be associated with these changes. Inflammation may be associated with compensatory activation of brain regions to offset structural changes. This emerging line of evidence suggests that communication between the brain and immune system are an important and underappreciated aspect of inflammatory rheumatic disease.
Entities:
Keywords:
Arthritis; Central nervous system sensitization; Inflammation; Magnetic resonance imaging; Rheumatoid
Authors: J Luyendijk; S C A Steens; W J N Ouwendijk; G M Steup-Beekman; E L E M Bollen; J van der Grond; T W J Huizinga; B J Emmer; M A van Buchem Journal: Arthritis Rheum Date: 2011-03
Authors: Mats Lekander; Bianka Karshikoff; Emilia Johansson; Anne Soop; Peter Fransson; Johan N Lundström; Anna Andreasson; Martin Ingvar; Predrag Petrovic; John Axelsson; Gustav Nilsonne Journal: Brain Behav Immun Date: 2015-12-28 Impact factor: 7.217
Authors: Daniel F McWilliams; Eamonn Ferguson; Adam Young; Patrick D W Kiely; David A Walsh Journal: Arthritis Res Ther Date: 2016-12-13 Impact factor: 5.156
Authors: Kristoffer A Zervides; Andreas Jern; Jessika Nystedt; Birgitta Gullstrand; Petra C Nilsson; Pia C Sundgren; Anders A Bengtsson; Andreas Jönsen Journal: BMC Rheumatol Date: 2022-07-09
Authors: Meghan A Koop; Ivo J Lutke Schipholt; Gwendolyne G M Scholten-Peeters; Michel W Coppieters Journal: Pain Med Date: 2021-11-26 Impact factor: 3.750